387 related articles for article (PubMed ID: 33864801)
21. Detection of novel
Ajibaye O; Olukosi YA; Oriero EC; Oboh MA; Iwalokun B; Nwankwo IC; Nnam CF; Adaramoye OV; Chukwemeka S; Okanazu J; Gabriel E; Balogun EO; Amambua-Ngwa A
Front Cell Infect Microbiol; 2024; 14():1366563. PubMed ID: 38716192
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N
Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
Malar J; 2009 May; 8():107. PubMed ID: 19454000
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
26. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
Maniga JN; Samuel M; John O; Rael M; Muchiri JN; Bwogo P; Martin O; Sankarapandian V; Wilberforce M; Albert O; Onkoba SK; Adebayo IA; Adeyemo RO; Akinola SA
Malar J; 2023 Mar; 22(1):87. PubMed ID: 36894982
[TBL] [Abstract][Full Text] [Related]
27. Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
Mihreteab S; Platon L; Berhane A; Stokes BH; Warsame M; Campagne P; Criscuolo A; Ma L; Petiot N; Doderer-Lang C; Legrand E; Ward KE; Zehaie Kassahun A; Ringwald P; Fidock DA; Ménard D
N Engl J Med; 2023 Sep; 389(13):1191-1202. PubMed ID: 37754284
[TBL] [Abstract][Full Text] [Related]
28. Selection of
Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
[TBL] [Abstract][Full Text] [Related]
30. Changing Pattern of Plasmodium falciparum
van Loon W; Bergmann C; Habarugira F; Tacoli C; Savelsberg D; Oliveira R; Mbarushimana D; Ndoli J; Sendegeya A; Bayingana C; Mockenhaupt FP
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0090121. PubMed ID: 34228534
[TBL] [Abstract][Full Text] [Related]
31. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
[TBL] [Abstract][Full Text] [Related]
33. Spread of artemisinin resistance in Plasmodium falciparum malaria.
Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
[TBL] [Abstract][Full Text] [Related]
34. Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.
Tacoli C; Gai PP; Bayingana C; Sifft K; Geus D; Ndoli J; Sendegeya A; Gahutu JB; Mockenhaupt FP
Am J Trop Med Hyg; 2016 Nov; 95(5):1090-1093. PubMed ID: 27573632
[TBL] [Abstract][Full Text] [Related]
35. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
36. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review.
Kayiba NK; Yobi DM; Tshibangu-Kabamba E; Tuan VP; Yamaoka Y; Devleesschauwer B; Mvumbi DM; Okitolonda Wemakoy E; De Mol P; Mvumbi GL; Hayette MP; Rosas-Aguirre A; Speybroeck N
Lancet Infect Dis; 2021 Apr; 21(4):e82-e92. PubMed ID: 33125913
[TBL] [Abstract][Full Text] [Related]
37. A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.
Oyebola KM; Aina OO; Idowu ET; Olukosi YA; Ajibaye OS; Otubanjo OA; Awolola TS; Awandare GA; Amambua-Ngwa A
BMC Infect Dis; 2018 Aug; 18(1):392. PubMed ID: 30103683
[TBL] [Abstract][Full Text] [Related]
38. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
[TBL] [Abstract][Full Text] [Related]
39. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
[TBL] [Abstract][Full Text] [Related]
40. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.
Bwire GM; Ngasala B; Mikomangwa WP; Kilonzi M; Kamuhabwa AAR
Sci Rep; 2020 Feb; 10(1):3500. PubMed ID: 32103124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
